An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease

[1]  A. Wood,et al.  From lipid locus to drug target through human genomics. , 2018, Cardiovascular research.

[2]  Nicola J. Rinaldi,et al.  Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics , 2018, Nature Communications.

[3]  Mary Goldman,et al.  Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics , 2016, Nature Communications.

[4]  K. Hao,et al.  A functional genomics predictive network model identifies regulators of inflammatory bowel disease , 2017, Nature Genetics.

[5]  Christian Gieger,et al.  Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis , 2017, PLoS Medicine.

[6]  Jens Nielsen,et al.  Network analyses identify liver‐specific targets for treating liver diseases , 2017, Molecular systems biology.

[7]  Kristin G Ardlie,et al.  Genetic Analysis in UK Biobank Links Insulin Resistance and Transendothelial Migration Pathways to Coronary Artery Disease , 2017, Nature Genetics.

[8]  Debbie A Lawlor,et al.  Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies , 2017, American journal of epidemiology.

[9]  Gaurav Pandey,et al.  Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. , 2017, Cell stem cell.

[10]  M. Huff,et al.  ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia , 2017, Current opinion in lipidology.

[11]  P. De Camilli,et al.  Lipid transport by TMEM24 at ER–plasma membrane contacts regulates pulsatile insulin secretion , 2017, Science.

[12]  U. Laufs,et al.  Pleiotropic Effects of Statins on the Cardiovascular System , 2017, Circulation research.

[13]  Inês Barroso,et al.  Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance , 2016, Nature Genetics.

[14]  Inês Barroso,et al.  Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis , 2016, PLoS medicine.

[15]  Sara M. Willems,et al.  Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. , 2016, JAMA.

[16]  S. Humphries,et al.  Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes. , 2016, JAMA cardiology.

[17]  Tom Michoel,et al.  Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases , 2016, Science.

[18]  Trieu Nguyen,et al.  Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci , 2016, Nature Communications.

[19]  Brian J. Bennett,et al.  The Hybrid Mouse Diversity Panel: a resource for systems genetics analyses of metabolic and cardiovascular traits , 2016, Journal of Lipid Research.

[20]  M. Shepherd,et al.  Use of Statins and the Risk of Incident Diabetes: A Retrospective Cohort Study , 2016, American Journal of Cardiovascular Drugs.

[21]  K. Maki,et al.  Statins and Diabetes. , 2016, Endocrinology and metabolism clinics of North America.

[22]  Andrew J. Brown,et al.  Cholesterol-mediated Degradation of 7-Dehydrocholesterol Reductase Switches the Balance from Cholesterol to Vitamin D Synthesis* , 2016, The Journal of Biological Chemistry.

[23]  C. Des Rosiers,et al.  PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[24]  Emmanouil T. Dermitzakis,et al.  Fast and efficient QTL mapper for thousands of molecular phenotypes , 2015, bioRxiv.

[25]  Ina Hoeschele,et al.  Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease , 2015, Diabetes.

[26]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[27]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[28]  R. Mägi,et al.  Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes , 2015, Diabetes.

[29]  J. Kastelein,et al.  Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. , 2015, JAMA.

[30]  Tom R. Gaunt,et al.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.

[31]  Pasi Soininen,et al.  Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.

[32]  Hynek Pikhart,et al.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.

[33]  Joshua D. Campbell,et al.  Integrative Analysis of DNA Methylation and Gene Expression Data Identifies EPAS1 as a Key Regulator of COPD , 2015, PLoS genetics.

[34]  Weiliang Qiu,et al.  Integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism analysis identifies novel pathway in allergic rhinitis , 2014, BMC Medical Genomics.

[35]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[36]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[37]  Dmitri Volfson,et al.  Computationally efficient permutation-based confidence interval estimation for tail-area FDR , 2013, Front. Genet..

[38]  Samin K. Sharma,et al.  Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). , 2013, Journal of the American College of Cardiology.

[39]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[40]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[41]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[42]  P. Libby,et al.  Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial , 2012, The Lancet.

[43]  Yudong D. He,et al.  Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers , 2012, Molecular systems biology.

[44]  Claude Bouchard,et al.  A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance , 2012, Nature Genetics.

[45]  Rachel B. Brem,et al.  Stitching together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation , 2012, PLoS biology.

[46]  Matko Bosnjak,et al.  REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.

[47]  Bin Zhang,et al.  A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. , 2011, Genome research.

[48]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[49]  J. Lubsen.  Statins and risk of incident diabetes , 2010, The Lancet.

[50]  W. Simpson.  Statins and risk of incident diabetes , 2010, The Lancet.

[51]  C. Cannon.  Balancing the benefits of statins versus a new risk—diabetes , 2010, The Lancet.

[52]  Yasuo Ohashi,et al.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2010, The Lancet.

[53]  E. Schadt,et al.  Integrating siRNA and protein-protein interaction data to identify an expanded insulin signaling network. , 2009, Genome research.

[54]  Eric E Schadt,et al.  Disentangling molecular relationships with a causal inference test , 2009, BMC Genetics.

[55]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[56]  Rachel B. Brem,et al.  Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks , 2008, Nature Genetics.

[57]  W. Feeman.  Statins and diabetes , 2008, The Lancet.

[58]  A. Lusis,et al.  Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance* , 2008, Journal of Biological Chemistry.

[59]  Jun Zhu,et al.  Increasing the Power to Detect Causal Associations by Combining Genotypic and Expression Data in Segregating Populations , 2007, PLoS Comput. Biol..

[60]  J. Castle,et al.  An integrative genomics approach to infer causal associations between gene expression and disease , 2005, Nature Genetics.

[61]  R. Hammer,et al.  Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  B. Song,et al.  Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. , 2005, Cell metabolism.

[63]  T. Schulz-Gasch,et al.  Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase , 2004, Nature.

[64]  J. Zhu,et al.  An integrative genomics approach to the reconstruction of gene networks in segregating populations , 2004, Cytogenetic and Genome Research.

[65]  J. Björkegren,et al.  The Low Density Lipoprotein Receptor Prevents Secretion of Dense ApoB100-containing Lipoproteins from the Liver* , 2004, Journal of Biological Chemistry.

[66]  Peter Libby,et al.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. , 2002, JAMA.

[67]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[68]  B. Eisele,et al.  Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo. , 1997, Journal of lipid research.

[69]  W. März,et al.  Analysis of plasma lipoproteins by ultracentrifugation in a new fixed angle rotor: evaluation of a phosphotungstic acid/MgCl2 precipitation and a quantitative lipoprotein electrophoresis assay. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[70]  A. Groen,et al.  Control of gluconeogenesis in rat liver cells. I. Kinetics of the individual enzymes and the effect of glucagon. , 1983, The Journal of biological chemistry.

[71]  G. Assmann,et al.  Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. , 1983, Clinical chemistry.

[72]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[73]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[74]  V. Pubul,et al.  and Cardiovascular Disease: What to , 2019 .

[75]  J. Björkegren,et al.  The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver. , 2004, The Journal of biological chemistry.

[76]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[77]  J. Qiao,et al.  Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.